Moleculin Biotech, Inc. License Agreements

21 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 4 to Patent and Technology License Agreement between University of Texas M.D. Anderson Cancer Center and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
TX
2021
Amendment No. 3 to Patent and Technology License Agreement between The University of Texas M. D. Anderson Cancer Center and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
TX
2020
Amendment No. 1 to Patent and Technology License Agreement between University of Texas M.D. Anderson Cancer Center and Intertech Bio Corporation
License Agreements
Moleculin Biotech, Inc.
Biotechnology
TX
2016
Patent and Technology License Agreement between The University of Texas System and Intertech Bio Corporation
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2016
Patent and Technology License Agreement between The University of Texas M.D. Anderson Cancer Center and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2023
Patent and Technology License Agreement between The University of Texas M.D. Anderson Cancer Center and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2022
Patent and Technology License Agreement between The University of Texas System and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2022
Patent and Technology License Agreement between The University of Texas M.D. Anderson Cancer Center and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2022
Amendment No. 1 to Patent and Technology License Agreement between The University of Texas M.D. Anderson Cancer Center and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2022
Patent and Technology License Agreement between The University of Texas System and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2022
Amended and Restated Sublicense Agreement between Moleculin Biotech Inc. and WPD Pharmaceuticals
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2021
Amended and Restated Sublicense Agreement between Moleculin Biotech Inc. and WPD Pharmaceuticals
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2021
Sublicense Agreement between Moleculin Biotech Inc. and Animal Life Sciences, LLC (February 19, 2019)
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2019
Sublicense Agreement between Moleculin Biotech Inc. and WPD Pharmaceuticals (February 19, 2019)
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2019
Patent and Technology License Agreement between The University of Texas M.D. Anderson Cancer Center and Moleculin Biotech, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2018
Technology Rights and Development License Agreement between Moleculin Biotech, Inc. and Houston Pharmaceuticals, Inc.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2016
Patent and Technology Development and License Agreement between Annamed, Inc. and Dermin Sp. z o.o.
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2016
Patent and Technology Development and License Agreement between Moleculin, LLC and Dermin LLC (October 27, 2010)
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2016
Patent and Technology Development and License Agreement between Intertech Bio Corporation and DERMIN LLC (April 15, 2011)
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2016
Amendment No. 1 to Patent and Technology License Agreement between University of Texas M.D. Anderson Cancer Center and Moleculin, LLC
License Agreements
Moleculin Biotech, Inc.
Biotechnology
TX
2016
Patent and Technology License Agreement between The University of Texas M.D. Anderson Cancer Center and Moleculin, LLC
License Agreements
Moleculin Biotech, Inc.
Biotechnology
2016